A serialization software comparison can be built around features, vendors, or price. But another factor to consider is who owns the operational work after go-live, including accountability when something goes wrong.
Manufacturers comparing serialization software by ownership can start with four areas of operational work: exception management, issue resolution, system maintenance, and trading partner support. For each option, three questions frame the comparison:
DSCSA enforcement deadlines now apply to manufacturers, repackagers, wholesale distributors, and all other dispensers. FDA has extended exemptions from certain requirements for qualifying small dispensers through November 27, 2027.
A 2026 analysis in Pharmaceutical Technology describes the industry as having largely completed the build phase of traceability. The open question is how organizations operationalize the serialized data those systems produce.
The same analysis describes a pattern in which organizations are technically compliant yet operationally fragile. Their systems perform under stable conditions but degrade under stress, such as partner outages, data mismatches, system changes, or peak distribution periods.
Each of those stress points creates work for someone, and a serialization software comparison organized around ownership makes clear who that is for each option you evaluate.
For purposes of comparing ownership models, operational work can be grouped into four areas. Each draws on different functions inside the organization, which is part of what makes ownership difficult to assign.
Serialization exceptions are data discrepancies or processing failures that can disrupt product movement if they aren't resolved. The PharmTech analysis lists aggregation mismatches, incomplete EPCIS events, and partner-specific formatting differences as examples of minor defects that can cascade to multiple downstream partners.
In large trading networks, the author notes that exception volume often grows disproportionately as the network scales. Resolving an exception means cross-referencing several sources:
The analysis also identifies a staffing issue. Resolution quality depends on individual expertise and familiarity with specific partners, and that variability increases during peak shipping periods and organizational transitions. According to the author, many organizations discover after go-live that scaling exception handling in line with headcount is neither sustainable nor effective.
Issue resolution is where ownership questions surface most directly. The PharmTech author gives the example of a minor aggregation discrepancy at a contract packaging site that propagates to distributor and dispenser nodes and triggers product quarantine. In his investigations, the technical defect itself was generally simple. Identifying ownership, aligning stakeholders, and coordinating corrective action took far more effort.
His recommended fix is an exception routing model that defines which team owns each category:
In a serialization software comparison, the routing question gets a different answer depending on how much of this work the provider owns.
System maintenance covers certificates, configuration changes, and platform updates. The PharmTech analysis singles out digital certificate expiry as a preventable cause of disruption. An expired certificate can block EPCIS transmissions without generating clear system-level alerts, and the problem often surfaces downstream as an unexplained product quarantine. Renewal can happen quickly, but the author notes that operational recovery can extend over an entire business cycle.
The controls he recommends each need an owner:
Serialization networks are interdependent. According to the PharmTech analysis, a configuration change, API update, or platform upgrade at a single wholesaler or 3PL can affect dozens of connected partners. When a 3PL acts as an agent for multiple manufacturers, accountability can become diffused, and the place where a failure occurs is often separate from the team that owns the fix.
The author recommends three controls:
Data quality is part of this area as well. Pharmaceutical Online, summarizing data presented at an FDA town hall, reported that HDA's expected levels of DSCSA-disrupted product due to missing or inaccurate manufacturer purchase order data improved from 25% to 9% between September 2024 and February 2025. HDA cautioned that the final 9% of data quality issues may be the hardest to fix.
The four areas can be divided between your organization and your serialization provider in different ways. The three models below describe the range, from your internal team handling all of the work to the provider including all of it in the engagement.
The provider supplies the platform. Your team handles exceptions, investigates issues, maintains configurations and certificates, and onboards and supports trading partners.
Your team staffs all four areas. That requires expertise in EPCIS data, partner configurations, certificate management, and exception investigation. It also requires coverage during peak periods and staff transitions, which are the times the PharmTech analysis identifies as most vulnerable to inconsistent resolution.
Your organization is accountable from end to end. Internally, the work still has to be routed between quality, distribution, IT, and operations, which is where the routing model described above applies.
Covectra's Executive Brief notes that this model works for large manufacturers with internal serialization specialists. For mid-size manufacturers without that bandwidth, it leaves the operational burden with the client.
The provider owns the platform and some portion of the operational work. Your internal staff, outside consultants, or support billed outside the base agreement handle the rest.
Your team covers whatever the provider does not and coordinates between the parties involved. The cost of the gaps appears in different places, whether as consulting fees, incident charges, or internal hours.
Accountability is split, and every boundary between parties is a handoff. This is where the PharmTech observation about ownership applies most directly. When a problem crosses from one party's scope into another's, someone has to establish who owns it before anyone can fix it.
This model depends on two things: how clearly the division of work is documented, and whether someone inside your organization has the authority to coordinate between parties.
Exception management, issue resolution, system maintenance, and trading partner support are included in the provider's engagement.
Your team sets requirements, makes business decisions, and works with the provider. Day-to-day resolution work in the four areas belongs to the provider. As the Executive Brief puts it, when the vendor takes on the operational complexity, the function stops consuming internal resources and starts generating information the business can use.
The provider owns the day-to-day operational work across all four areas.
The Executive Brief describes this model as designed for organizations without dedicated internal serialization specialists, including mid-size manufacturers and virtual brand owners.
|
Internal Team Owns |
Shared Ownership |
Provider Owns |
|
|
Exception management |
Internal staff |
Split by agreement |
Provider |
|
Issue resolution |
Internal staff |
Split by agreement |
Provider |
|
System maintenance |
Internal staff |
Split by agreement |
Provider |
|
Trading partner support |
Internal staff |
Split by agreement |
Provider |
|
Internal expertise assumed |
Dedicated specialists |
Enough to cover gaps and coordinate |
Requirements and decisions |
|
Accountability for resolution |
Your organization |
Divided between parties |
Provider |
Serialization Doesn't Have to Be a Cost of Doing Business
Covectra's Executive Brief looks at how early DSCSA vendor decisions shaped the serialization market. It examines what an underperforming vendor relationship costs the business, often in ways that are spread among departments and never traced back to the vendor. It also describes what serialization looks like when the vendor owns the operational complexity.
A useful starting point is a clear picture of how the four areas are handled today. For each area, document who does the work and how much time it takes.
For exception management, the PharmTech analysis suggests a concrete method:
That baseline shows how much work each ownership model would need to absorb, and which parts of it fall to your team under each option.
From there, confirm in writing which party owns each of the four areas for every option you are considering. For the questions to ask providers about service model, platform, pricing, and transition, use our serialization vendor evaluation checklist.
Covectra's model is designed for organizations that need a serialization provider to own operational complexity rather than redistribute it. Covectra's pharmaceutical serialization services include exception management, issue resolution, system maintenance, and trading partner support as part of the engagement.
The platform is built for teams without dedicated internal serialization specialists, and implementation support is provided end to end.
AuthentiTrack is Covectra's serialization and track and trace platform. It is EPCIS certified and built around a serial event history repository, and it supports DSCSA compliance in the trading partner network. Its secure data gateway enables interoperability between contract manufacturers and brand owners' traceability systems, which suits virtual brand owners managing product data with multiple CMOs.
Compare the options by who does the operational work after go-live. For each option, identify which party handles exception management, issue resolution, system maintenance, and trading partner support, and how much internal expertise the arrangement assumes.
The work falls into four areas: exception management, issue resolution, system maintenance (including certificate management and platform updates), and trading partner support. Each area draws on different functions, including quality, distribution, IT, and operations.
It depends on the ownership model. Exception management can belong to your internal team, be split between your team and outside support, or be included in the provider's engagement. Confirm in writing which applies before signing.
It depends on how much of the operational work the provider takes on. Models that assume dedicated internal specialists leave the operational burden with your team. Covectra's platform is built for teams without dedicated internal serialization specialists.
Yes. Exception management, issue resolution, system maintenance, and trading partner support are included as part of Covectra's engagement, and implementation is supported end to end.
If your serialization software comparison has raised questions about who owns the operational work today, Covectra's Executive Brief takes the analysis further. It covers four topics:
Keep Learning